NORTHERN CALIFORNIA RHEUMATOLOGY SOCIETY (EIN 264371408) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2009

Legal Domicile

Principal Officer

BARRY SHIBUYA

Phone

5107911300

Tax Period

2023-01-01 to 2023-12-31

NORTHERN CALIFORNIA RHEUMATOLOGY SOCIETY, founded in 2009, is a micro nonprofit that reported $44K in total revenue in fiscal year 2023. Revenue fell 77% from the prior year — a significant decline worth monitoring. Expenses of $125K exceeded revenue, resulting in a 185% operating deficit.

Mission

PROVIDE FOR THE ADVANCEMENT OF THE CARE OF PATIENTS WITH RHEUMATIC AND RELATED DISEASES THROUGH THE PROFESSIONAL DEVELOPMENT OF ITS MEMBERS, VIA EDUCATIONAL PROGRAMS ON RECENT SCIENTIFIC ADVANCES IN THE FIELD AND PRACTICE OF RHEUMATOLOGY AND RELATED MEDICAL SPECIALTIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $43,500

Program Service Revenue $0

Investment Income $454

Other Revenue $0

TOTAL REVENUE $43,954

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $102,414

Other Expenses $125,239

TOTAL EXPENSES $125,239

Year-over-Year Comparison

	2023	2022	Change
Revenue	$43,954	$190,584	-0.8%
Expenses	$125,239	$102,072	+0.2%
Net Income	$-81,285	$88,512	-1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BARRY SHIBUYA MD	EXECUTIVE DIRECTOR	5.00	Officer	$0	$0	$0
SUDHAKAR TUMULURI MD	PRESIDENT	5.00	Officer	$0	$0	$0
LYNDA LEE MD	TREASURER	5.00	Officer	$0	$0	$0
DR SANGEETHA BALASUBRAMANIAN	SECRETARY	5.00	Officer	$0	$0	$0
AMIEE LOO	PROGRAM DIRECTOR	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$43,954	$125,239	$538,246	$-81,285
2022	$190,584	$102,072	$619,531	$88,512
2021	$126,533	$60,281	$531,019	$66,252

NORTHERN CALIFORNIA RHEUMATOLOGY SOCIETY